ARCHIVES

NCI Branch Chiefs, ACCI Join Support For DeVita

This article is from The Cancer Letter archive.

Vol. 07 No. 26 | June 25, 1981

Download PDF Visit The Full Archive

Related Articles

FDA Policy On Support Of Medical Education Near Final Form

February 5, 1993

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

Fragmin Cuts Risk Of VE By 50 Percent In Study

January 31, 2003

Brain tumor foundations form collaboration.

July 15, 2005

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

Patients Report Clinical Trials Not Offered By Physician

June 27, 2008